The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001003369
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
29/04/2026
Date registered
Help: Date registered
14/08/2026
Date last updated
Help: Date last updated
14/08/2026
Date data sharing statement initially provided
Help: Data sharing statement date
14/08/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
HeartPath+: A single site effectiveness/implementation feasibility study to test the co-designed HeartPath+ website for patients with coronary heart disease

Scientific title
HeartPath+: A single site pilot Type 1 hybrid effectiveness/implementation feasibility study to test the co-designed HeartPath+ website for patients with coronary heart disease
Additional trial identifiers [1] 317550 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Coronary Artery Disease 340186 0
Coronary Heart Disease 340187 0
Acute Coronary Syndrome 340188 0
Myocardial Infarction 341678 0
Condition category
Condition code
Cardiovascular 336382 336382 0 0
Coronary heart disease
Cardiovascular 338404 338404 0 0
Diseases of the vasculature and circulation including the lymphatic system
Cardiovascular 338405 338405 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
HeartPath+ website is a a digital educational and transition of care resource co-designed with consumers/ lived experience investigators for cardiac patients presenting with a coronary heart disease. The HeartPath+ website is looking to provide information and support to patients in the early stages after experiencing a coronary heart event.

This website was co-designed by consumers and family members, in three groups of consumers across those who spoke English, Mandarin and Russian. We used experience-based co-design to run co-design workshops and analysed data using the Health Literacy Model. In total we ran six English workshops, two in Mandarin and two in Russian. A content analysis was conducted which guided main content on the website. Every participant was then able to review the draft website and provide further feedback and opt in to user testing. Randomisation will occur at the ward level. One out of two wards will receive the intervention. All patients on this ward will receive access to the digital intervention during their hospital stay. This will be in addition to usual care.

The HeartPath+ website will cover topics that are commonly asked in the earlier stages of recovery after a coronary heart event such as mental health/cardiac blues, eating styles/ habits, gentle exercises and medication. The website will be available in English with key sections (ie. Cardiac rehabilitation information, diet and mental health – as requested by consumers) translated into Mandarin and Russian. Content will be written with the ability for some sections to be printed out. Short videos with the lead researcher (Dr Susie Cartledge) and lived experienced consumers (in both Mandarin and Russian) will also be features on the website.

Participants will be able to access the website through their own personal device. A link can be sent to either their mobile device or email address. Ward specific devices (such as an iPad or tablet) will also be made available.

The HeartPath+ website will be introduced to the participants by a registered nurse looking after them or with a research staff member. Participants who consent to taking part in the research project will have data collected at baseline (during hospital stay) and 90 days follow up (post hospital stay). They will complete questionnaires at both timepoints and have basic but limited data analytics on the frequency and duration of use of the HeartPath+ website. Questionnaires will evaluate on whether the HeartPath+ will empower and assist participants in actively managing their heart health (primary effectiveness outcome, designated by consumers).
Intervention code [1] 332818 0
Rehabilitation
Intervention code [2] 332819 0
Lifestyle
Description of the comparator or control
The control group will not receive access the HeartPath+ website during the study duration and only continue with current practice for in-hospital education and educational resources that are given (if given) to them at time of discharge as part of usual care.

The control group may receive access to HeartPath+ after completing the study (at 90 days).

Current standard of care varies between patients and nurses. It also varies from each organisation. Some patients may receive a quick education during their hospital stay. Examples of some brochures that may be used include a “Cardiac Blues” patient resource, a chest pain management plan, a nursing discharge record, a medication summary. The education is given by nurses and allied health professionals. The HeartPath+ website aim is to address that gap and allow patients to have control of when they wish to access the information and how frequently they wish to revisit the information. In-hospital education can vary depending on the nurse looking after the patient.

Control group
Placebo

Outcomes
Primary outcome [1] 343903 0
Patients’ confidence in being able to actively manage their health using the health literacy questionnaire -3.
Timepoint [1] 343903 0
Baseline and 90 days post hospital discharge
Secondary outcome [1] 456062 0
Patients' Self-Efficacy
Timepoint [1] 456062 0
Baseline and 90 days post hospital discharge
Secondary outcome [2] 456063 0
Patients' quality of life
Timepoint [2] 456063 0
Baseline and 90 days post hospital discharge
Secondary outcome [3] 461079 0
Patient Reported Experience Measures
Timepoint [3] 461079 0
90 days post hospital discharge
Secondary outcome [4] 461080 0
Cardiac Rehabilitation Process Indicators
Timepoint [4] 461080 0
90 days post hospital discharge
Secondary outcome [5] 461081 0
Cost effectiveness
Timepoint [5] 461081 0
90 days post hospital discharge
Secondary outcome [6] 463286 0
Coronary Artery Disease Education Questionnaire - Short Version will be used to evaluate if the HeartPath+ website will improve participants' cardiac knowledge
Timepoint [6] 463286 0
Baseline and 90 days post hospital discharge
Secondary outcome [7] 463287 0
Patient Quality of Life (depression) using the Patient Health Questionnaire - 9
Timepoint [7] 463287 0
Baseline and 90 days post hospital discharge
Secondary outcome [8] 463288 0
Quality of Life (Anxiety) to evaluate if the HeartPath+ website improves anxiety at 90 days post hospital discharge.
Timepoint [8] 463288 0
Baseline and 90 days post hospital discharge
Secondary outcome [9] 463306 0
Mediterranean Diet Adherence/ Improvement
Timepoint [9] 463306 0
Baseline and 90 days post hospital discharge
Secondary outcome [10] 465837 0
Patients’ confidence in feeling understood and supported by healthcare providers using the health literacy questionnaire - 1.
Timepoint [10] 465837 0
Baseline and 90 days post hospital discharge
Secondary outcome [11] 465838 0
Patients' confidence in having sufficient information to manage their health using the health literacy questionnaire - 2
Timepoint [11] 465838 0
Baseline and 90 days post hospital discharge
Secondary outcome [12] 465839 0
Patients' confidence in navigating the healthcare system using the health literacy questionnaire - 7
Timepoint [12] 465839 0
Baseline and 90 days post hospital discharge
Secondary outcome [13] 465840 0
Patients' confidence in understanding health information well enough to know what to do using the health literacy questionnaire - 9
Timepoint [13] 465840 0
Baseline and 90 days post hospital discharge

Eligibility
Key inclusion criteria
Participants will be eligible for the study if ALL of the following inclusion criteria are met:
1. Aged 18 years and over
2. Able to provide informed consent in English or in preferred language of Mandarin or Russian with an interpreter present
3. Diagnosis of coronary heart disease (CHD) (angina and all forms of acute coronary syndrome)
4. Lives independently at home
5. Has access to a device which can connect to the HeartPath+ website
6. Willing to access the HeartPath+ website (if in the intervention arm) and complete study requirements
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Participants be ineligible for the study if ANY of the following exclusion criteria apply:
1. Unable to provide consent
2. Living in supported accommodation or aged care
3. Clinically unstable/unwell (e.g currently in ICU)
4. Terminal diagnosis
5. Participant not willing to use the HeartPath+ website or is unable to access the site

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The two clusters will be randomly allocated (1:1) to intervention or control via drawing a random number in Stata. Randomisation will occur at the ward level of two wards, therefore we will have two clusters. Randomisation will be performed after cluster enrolment and prior to outcome assessment.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 29647 0
The Alfred - Melbourne
Recruitment postcode(s) [1] 45992 0
3004 - Melbourne

Funding & Sponsors
Funding source category [1] 320790 0
Government body
Name [1] 320790 0
Australian Department of Health & Aged Care, Stream 1 Consumer-Led Research, Medical Research Future Fund (MRFF)
Country [1] 320790 0
Australia
Primary sponsor type
University
Name
Monash University
Address
Country
Australia
Secondary sponsor category [1] 323453 0
Government body
Name [1] 323453 0
Australian Department of Health & Aged Care, Stream 1 Consumer-Led Research, Medical Research Future Fund (MRFF)
Address [1] 323453 0
Country [1] 323453 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319322 0
Alfred Hospital Ethics Committee
Ethics committee address [1] 319322 0
Ethics committee country [1] 319322 0
Australia
Date submitted for ethics approval [1] 319322 0
06/05/2026
Approval date [1] 319322 0
18/06/2026
Ethics approval number [1] 319322 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 146974 0
Dr Susan (Susie) Cartledge
Address 146974 0
Monash University, L4, 553 St Kilda Road Melbourne VIC 3004 Australia
Country 146974 0
Australia
Phone 146974 0
+61 3 9903 0764
Fax 146974 0
Email 146974 0
Contact person for public queries
Name 146975 0
Susan (Susie) Cartledge
Address 146975 0
Monash University, L4, 553 St Kilda Road Melbourne VIC 3004 Australia
Country 146975 0
Australia
Phone 146975 0
+61 3 9903 0764
Fax 146975 0
Email 146975 0
Contact person for scientific queries
Name 146976 0
Susan (Susie) Cartledge
Address 146976 0
Monash University, L4, 553 St Kilda Road Melbourne VIC 3004 Australia
Country 146976 0
Australia
Phone 146976 0
+61 3 9903 0764
Fax 146976 0
Email 146976 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• De-identified individual participant data:
• All outcomes data
• Primary outcome(s)
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
A finite period of: 7 years
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: Dr Susie Cartledge who is the Chief Investigator and trial custodian.

Email address: [email protected]


Are there extra considerations when requesting access to individual participant data?
Yes: Ethics approval and data sharing agreements. Only study investigators/staff will be able to request to study data. External collaborators will need to be considered by Dr Susie Cartledge before access will be allowed.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.